Seeking Alpha

SciClone Pharma beats by $0.01, misses on revenue

  • SciClone Pharmaceuticals (SCLN): Q2 EPS of $0.08 beats by $0.01.
  • Revenue of $29.3M misses by $4.M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)